Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Thomas Otten (), Rob Riemsma, Ben Wijnen, Nigel Armstrong, Lisa Stirk, Caroline Gordon, Bram Ramaekers, Jos Kleijnen, Manuela Joore and Sabine Grimm
Additional contact information
Thomas Otten: Maastricht University Medical Centre+ (MUMC+)
Rob Riemsma: Kleijnen Systematic Reviews Ltd
Ben Wijnen: Maastricht University Medical Centre+ (MUMC+)
Nigel Armstrong: Kleijnen Systematic Reviews Ltd
Lisa Stirk: Kleijnen Systematic Reviews Ltd
Caroline Gordon: Kleijnen Systematic Reviews Ltd
Bram Ramaekers: Maastricht University Medical Centre+ (MUMC+)
Jos Kleijnen: Kleijnen Systematic Reviews Ltd
Manuela Joore: Maastricht University Medical Centre+ (MUMC+)
Sabine Grimm: Maastricht University Medical Centre+ (MUMC+)

PharmacoEconomics, 2023, vol. 41, issue 11, No 9, 1551 pages

Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-023-01315-1 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:41:y:2023:i:11:d:10.1007_s40273-023-01315-1

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-023-01315-1

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().